ELF3 (E74 like ETS transcription factor 3) promotes tumor growth and autophagy in pancreatic cancer
It is observed that high expression of ELF3 leads to a poor overall survival in pancreatic cancer patients and SRT2183, an ELF3-targeting compound that suppresses autophagic flux and tumor growth, represents a promising candidate for further therapeutic development.